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BACKGROUND: The purpose of this study was to propose a new method for imaging the uterine cavity and
Fallopian tube patency by three-dimensional dynamic magnetic resonance hysterosalpingography (3D dMR-HSG)
and to analyse if, by using a higher viscosity contrast solution, direct visualization of the Fallopian tubes may be
achieved by this new technique. METHODS: 10 consecutive infertile women underwent 3D dMR-HSG and
conventional HSG as gold standard. 3D dMR-HSG consisted of injection of 20 ml of a gadolinium-polyvidone
solution into the uterine cavity while acquiring five consecutive three-dimensional (3D) T1-weighted MR-sequences.
RESULTS: In three patients the catheter became dislodged during 3D dMR-HSG. However, in one of these patients
the examination was still partially diagnostic. Imaging findings of 3D dMR-HSG showed good correlation with
conventional hysterosalpingography and allowed 3D imaging of the uterine cavity and of Fallopian tube patency in
8/10 patients and direct visualization of the Fallopian tubes in 5/7 patients. CONCLUSION: 3D dMR-HSG
represents a new and promising imaging approach to female infertility causing less pain and avoiding exposure of
the ovaries to ionizing radiation. By using a higher viscosity MR-contrast agent it allows not only visualization of
uterine cavity and Fallopian tube patency but also direct visualization of Fallopian tubes.
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Introduction
Although it can be shown that ultrasound with saline solution
is the best method to study the uterine cavity and although
contrast enhanced hystero-salpingo-sonography allows visual-
ization of the uterine cavity as well as Fallopian tube patency,
conventional (X-ray) hysterosalpingography (HSG) remains
the most commonly used procedure for imaging the uterine
cavity, the Fallopian tubes and Fallopian tube patency in
the evaluation of female infertility (Yoder and Hall, 1991;
Krysiewics, 1992; Reis et al., 1998; Boudghene et al., 2001).
However, conventional HSG is painful and leads unavoidably
to an application of ionizing radiation to the reproductive
organs of young and potentially fertile women. Furthermore,
many other causes of female infertility cannot be diagnosed
by X-ray-HSG and, therefore, many of these patients not only
undergo conventional HSG but additionally also trans-
abdominal and endovaginal sonography (Philipsen, Hansen,
1981; Fayez et al., 1988; Yoder and Hall, 1991; Krysiewics,
1992; Reis et al., 1998; Boudghene et al., 2001). In the past,
the leading role of magnetic resonance imaging (MRI) as an
additional examination in the evaluation of female infertility
has been well established since MRI proved to have a very
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high accuracy in detecting various pelvic, uterine and ovarian
pathologies (Philipsen, Hansen, 1981; Dudiak et al., 1988;
Carrington et al., 1990; Dykes et al., 1991; Mitchell, 1992;
Pellerito et al., 1992; Woodward et al., 1993; Ascher et al.,
1995). Furthermore it could be shown that imaging the uterine
cavity and Fallopian tube patency is possible by MR-HSG but
until now, direct visualization of the Fallopian tubes could not
be achieved by MR-HSG (Lee et al., 1996; Frye et al., 2000;
Hagspiel et al., 2000; Rouanet et al., 2000; Wiesner et al.,
2001). Therefore, the purpose of our study was to analyse if,
by using a special higher viscosity MR-HSG-contrast solution
composed especially and exclusively for this purpose, standard
pelvic MRI could be combined with MR-HSG in order to
enable a one-step imaging procedure for evaluation of female
infertility with the advantages of causing less pain and avoid-
ance of exposure to ionizing radiation.
Materials and methods
After the present study had been approved by the local ethics
committee, 10 consecutive infertile women (age range: 22–41years;
mean age: 33.8), who presented in our Division of Gynecological
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Figure 1. Three dimensional dynamic MR-HSG with overview maximum intensity projections acquired early during uterine injection of a
higher viscosity gadolinium-polyvidone solution allows perfect 3D visualization of the uterine cavity within the body from different views.
Left anterior oblique projection (A) and an inferior–superior projection (B). Note: the uterus is not only slightly anteflected but also mildly
positioned to the left. Uterine cavity (large arrow in A and B), colonic content (small arrows in A and B), vulva and rima ani (arrowhead in
A and B, respectively).
Endocrinology and Reproductive Medicine for evaluation of female
infertility and who were willing to participate, were included into
our study. Written informed consent had been obtained from all
patients to perform both MR-HSG and conventional HSG within
2 hours. The weight of our patients ranged from 46 to 103 kg (mean:
64.4). Their body height ranged from 155–176 cm (mean: 167.2).
As a first step uterine cannulation was performed by a gynaecologist
using a balloon catheter (Charriere 8, Ru¨sch, Kernen, Germany)
which was placed into the uterine cavity and blocked at its position.
MR-imaging was performed in a 1.5 Tesla MR-unit (Symphony,
Siemens, Erlagen). For imaging of the true pelvis standard axial and
sagittal T1-w and T2-w sequences were acquired. For 3D dMR-HSG
a fat-saturated 3D gradient-echo sequence was acquired with a phased
array body coil (‘FLASH 3D’: TE/TR 3.6/1.4, Flip-angle 25, FOV
380mm, slice thickness 1.25mm, voxel size 1.40.71.3mm).
By using this three dimensional T1-weighted sequence, five consec-
utive data sets were acquired before, at the beginning, during early,
during late, and after uterine injection of 20 ml of a strictly
germ-free gadolinium-polyvidone gel solution which was formulated
exclusively for this purpose.
The solution consisted of 18.6mmol/l Dotarem® (Acidum gadoteras
DCI, Guerbet, Paris, France) mixed with polyvidone (140 mg PVP
C30). Dotarem®, is a well known macrocyclic gadolinium-chelate
complex used worldwide as a paramagnetic MR-contrast agent
primarily for intravenous usage. However, since Dotarem® is an
extracellular contrast agent it may also be used as a positive intestinal
contrast agent for example for MR-colonographies or MR-enteroclyses
and extravasation of Dotarem® into the peritoneal cavity is therefore
harmless. Furthermore, Dotarem® is chemically very stable, does not
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bind to albumins or other proteins and does not undergo any
metabolism. Therefore Dotarem® behaves intracorporally as other
water-soluble and inert substances (such as mannitol or inulin) and
is cleared by renal excretion within 24 hours. Polyvidone on the other
hand is a viscosity increasing substance that is regularly used in
conventional HSG contrast media such as Telebrix-Hystero (Guerbet,
Paris France).
Viscosity of our slightly hyperosmolar contrast solution
(600mOsm/kg H2O) could thus be increased up to 100 mPa·s. Each
3D acquisition took only 20–25 s. All patients underwent X-ray-HSG
as a gold-standard immediately following 3D dMR-HSG and both
examinations were performed by the same gynaecologist and by the
same radiologist. Finally all patients (who did not receive any
anaesthesia or analgesia for HSG) were interrogated regarding their
experiences during both procedures.
Results
Standard T1-w and T2-w images were used to exclude anatom-
ical malformations, fibroids, endometriosis, tumours, cysts or
other pathologies of the genital tract as is usually carried out
in daily practice. This was possible in all patients. Positioning
of the catheter was always feasible. However, in three patients
the catheter slipped back into the vagina during the examina-
tion. While in two of these patients this happened at the
beginning of our examination resulting in a non-diagnostic
MR-HSG, in one patient it happened at the end of the
examination and MR-HSG was still diagnostic regarding
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Figure 2. Three dimensional dynamic MR-HSG with maximum intensity projections (MIP) acquired early (A) and during late (B) as well
as after (C) uterine injection of a gadolinium-polyvidone solution allows perfect 3D visualization of the uterine cavity (large arrowhead in
A), and of the ampullary parts of the tubes (small arrowheads in A, B, C and D) as well as free contrast accumulation in the peritoneal
cavity (arrows in A, B and C) proving bilateral Fallopian tube patency. Multiplanar thin slice MIP-reconstructions (D) additionally allow
visualization of the isthmic parts of the Fallopian tubes (arrow in D).
visualization of uterine cavity and demonstration of Fallopian
tube patency.
The use of 3D dMR-HSG allowed 3D visualization of a
normal uterine cavity in eight patients and confirmation of
bilateral Fallopian tube patency in six, which correlated with
findings of conventional HSG (Figures 1 and 2). In two patients
MR-HSG showed a one-sided occlusion of the Fallopian tubes
which was confirmed by X-ray-HSG. Furthermore, due to the
higher viscosity of our contrast solution, direct visualization
of the Fallopian tubes was possible in five of seven patients
(Figure 2).
One patient with catheter dislocation felt mild pain when
the catheter slipped back into her vagina but the remaining
9/10 patients stated that MR-HSG was significantly less painful
than X-ray-HSG.
Discussion
At present, MRI is the most accurate method for the non-
invasive diagnosis of various pelvic pathologies (Dudiak et al.,
1988; Carrington et al., 1990; Dykes et al., 1991; Mitchell
1992; Pellerito et al., 1992; Woodward et al., 1993; Ascher
et al., 1995). Due to an excellent resolution, direct visualization
of the reproductive organs, multiplanar imaging and avoidance
of radiation, MRI is therefore used worldwide as an additional
examination in the evaluation of female infertility. However,
so far in the daily routine, Fallopian tube patency is diagnosed
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by conventional X-ray-HSG, a method which is often painful
due to osmotic irritation of endometrial and peritoneal tissue
by iodinated contrast agents and which also leads to an
application of ionizing radiation to the genital organs of
young and potentially fertile women (Yoder and Hall, 1991;
Krysiewics, 1992).
Proof of Fallopian tube patency may also be achieved
by laparoscopy and by contrast enhanced sonography, but
laparoscopy fails to provide visualization of the uterine cavity
and contrast enhanced sonography has the disadvantage of
being more observer dependent and, therefore, less reproducible
(Philipsen, Hansen, 1981; Fayez et al., 1988; Reis et al., 1998;
Boudghene et al., 2001). Furthermore, a variety of other
possible causes for female infertility cannot be diagnosed
accurately by conventional HSG and sonography and, therefore,
many patients who are additionally referred for pelvic MRI
finally have to undergo more than one of the aforementioned
examinations.
Over the past years research activities on MR-HSG were
intensified but 3D and dynamic visualization of the human
uterine cavity and of Fallopian tube patency, together with
direct visualization of Fallopian tubes has not yet been achieved
(Lee et al., 1996; Frye et al., 2000; Hagspiel et al., 2000;
Rouanet et al., 2000; Wiesner et al., 2001). Therefore, com-
bined with standard pelvic MRI our method represents a
possible one-step imaging approach to female infertility.
The fact that dislocation of the catheter occurred in three
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patients was a limitation and it is possible that this happened
during the transfer to the MR system, where catheter reposi-
tioning was not possible anymore due to the narrow MR tube;
however using open MR systems in which catheter positioning
and repositioning could be done easily within the MR unit
might solve this problem.
Further research and further technical optimization is needed
as well as larger blinded comparative studies to evaluate the
diagnostic accuracy of this method in regard to detection of
various uterine and Fallopian pathologies compared with
conventional HSG, laparoscopy and sonography.
However, one can state at the moment that the advantages
of less pain during the examination, of more information about
all organs of the true pelvis and especially of avoidance of
exposure to ionizing radiation, do compensate for the longer
examination time and for the expected higher costs of this new
technique, which might evolve to a well-accepted alternative to
conventional HSG and probably even replace this old method
in the near future.
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